VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 19 filers reported holding VBI VACCINES INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $15,857,506 | -22.3% | 52,335,002 | 0.0% | 0.47% | -18.3% |
Q4 2022 | $20,410,650 | -45.1% | 52,335,002 | 0.0% | 0.57% | -46.8% |
Q3 2022 | $37,157,000 | -12.2% | 52,335,002 | 0.0% | 1.08% | -18.6% |
Q2 2022 | $42,312,000 | -51.3% | 52,335,002 | 0.0% | 1.32% | -23.9% |
Q1 2022 | $86,876,000 | -64.5% | 52,335,002 | -50.0% | 1.74% | -7.9% |
Q4 2021 | $244,926,000 | +43.1% | 104,670,004 | +90.2% | 1.89% | -24.0% |
Q3 2021 | $171,182,000 | -53.6% | 55,042,465 | -50.0% | 2.49% | +3.8% |
Q2 2021 | $368,784,000 | +115.4% | 110,084,930 | +100.0% | 2.40% | +10.6% |
Q1 2021 | $171,182,000 | +13.1% | 55,042,465 | 0.0% | 2.16% | +33.3% |
Q4 2020 | $151,366,000 | -3.8% | 55,042,465 | 0.0% | 1.62% | -29.3% |
Q3 2020 | $157,421,000 | -7.7% | 55,042,465 | 0.0% | 2.30% | -16.9% |
Q2 2020 | $170,631,000 | +290.9% | 55,042,465 | +19.8% | 2.76% | +143.2% |
Q1 2020 | $43,653,000 | -31.2% | 45,951,556 | 0.0% | 1.14% | -9.8% |
Q4 2019 | $63,413,000 | +38.0% | 45,951,556 | 0.0% | 1.26% | +1.8% |
Q3 2019 | $45,951,000 | +86.7% | 45,951,556 | +77.1% | 1.24% | +119.1% |
Q2 2019 | $24,607,000 | -42.3% | 25,951,556 | +8.4% | 0.56% | -53.0% |
Q1 2019 | $42,633,000 | +11.2% | 23,951,556 | 0.0% | 1.20% | -17.5% |
Q4 2018 | $38,322,000 | +63.8% | 23,951,556 | +147.8% | 1.46% | +133.3% |
Q3 2018 | $23,391,000 | -12.0% | 9,665,843 | 0.0% | 0.62% | -10.3% |
Q2 2018 | $26,581,000 | -21.4% | 9,665,843 | 0.0% | 0.70% | -26.5% |
Q1 2018 | $33,830,000 | -18.0% | 9,665,843 | 0.0% | 0.95% | -30.7% |
Q4 2017 | $41,273,000 | -18.4% | 9,665,843 | -26.4% | 1.37% | +41.8% |
Q3 2017 | $50,556,000 | +77.0% | 13,131,686 | +100.0% | 0.96% | -32.8% |
Q2 2017 | $28,561,000 | -20.8% | 6,565,843 | 0.0% | 1.44% | -30.0% |
Q1 2017 | $36,046,000 | +77.1% | 6,565,843 | 0.0% | 2.05% | +41.9% |
Q4 2016 | $20,354,000 | +94.0% | 6,565,843 | +114.7% | 1.45% | +113.7% |
Q3 2016 | $10,490,000 | – | 3,058,433 | – | 0.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
ArchPoint Investors | 65,000 | $202,000 | 0.06% |
FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
Ergoteles LLC | 171,127 | $532,000 | 0.02% |
J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |